ACTIVE

International Medical Consulting Company

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result7 k €+100,3 %over 1 year
Gross margin55,2 k €+7,7 %over 1 year
Equity242,9 k €+3,0 %over 1 year

Identity

Source · BCE/KBO

International Medical Consulting Company is a Private limited company incorporated in 2011. Its main activity is: Market research and public opinion polling. Its registered office is in Pelt.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0835.941.347
Incorporation
02/05/2011
Legal form
Private limited company
Registered office
Langveldweg 34
3910 Pelt · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 13 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin55,2 k €51,3 k €70,4 k €58,2 k €95 k €
EBITDA52,6 k €49,3 k €66,5 k €55,5 k €91,8 k €
Operating result10 k €8 k €36,1 k €26,1 k €69,1 k €
Net result7 k €3,5 k €24,1 k €16,4 k €46,1 k €
Balance sheet
Equity242,9 k €235,9 k €287 k €262,9 k €246,5 k €
Total assets258,9 k €299,3 k €299,2 k €294,8 k €285 k €
Cash29,1 k €39,5 k €77,8 k €50,7 k €41,4 k €
Debts15,9 k €63,4 k €12,2 k €31,9 k €38,5 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

DirectorFunctionMandate
LUDIVINE CANTIN
Director

Ended mandates

DirectorFunctionMandate
JOHANNES REIJNEN
Director01/01/2023 → 15/12/2023
LUDIVINE CANTIN
Directorsince 01/04/2021
JAN REIJEN
Manager
JAN REIJNEN
Director

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date27/08/202623/06/202531/07/202420/09/202328/07/202229/06/2021
General meeting26/05/202627/05/202531/05/202429/05/202330/05/202231/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 13 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202526/05/202627/08/2026DutchPDF
Micro model31/12/202427/05/202523/06/2025DutchPDF
Micro model31/12/202331/05/202431/07/2024DutchPDF
Micro model31/12/202229/05/202320/09/2023DutchPDF
Micro model31/12/202130/05/202228/07/2022DutchPDF
Micro model31/12/202031/05/202129/06/2021DutchPDF
Micro model31/12/201925/05/202025/09/2020DutchPDF
Micro model31/12/201827/05/201914/10/2019DutchPDF
Micro model31/12/201728/05/201808/10/2018DutchPDF
Micro model31/12/201629/05/201725/08/2017DutchPDF
Abridged model31/12/201530/05/201629/09/2016DutchPDF
Abridged model31/12/201330/05/201428/08/2014DutchPDF
Abridged model31/12/201231/05/201330/07/2013DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

DirectorFunctionMandate
LUDIVINE CANTIN
Director

Ended mandates

DirectorFunctionMandate
JOHANNES REIJNEN
Director01/01/2023 → 15/12/2023
LUDIVINE CANTIN
Directorsince 01/04/2021
JAN REIJEN
Manager
JAN REIJNEN
Director

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/12/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates28/05/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other04/05/2011
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20257 k €↑
  2. 2024
    Annual accounts 20243,5 k €↓
  3. 2023
    Annual accounts 202324,1 k €↑
  4. 2022
    Annual accounts 202216,4 k €↓
  5. 2021
    Annual accounts 202146,1 k €↑
  6. 2021
    Name changeIMCC
  7. 2020
    Annual accounts 202010,3 k €↓
  8. 2019
    Annual accounts 201911,1 k €↓
  9. 2018
    Annual accounts 201843,5 k €↑
  10. 2017
    Annual accounts 201743 k €↑
  11. 2016
    Annual accounts 201633,3 k €↓
  12. 2015
    Annual accounts 201534,3 k €↑
  13. 2013
    Annual accounts 201324,7 k €↑
  14. 2012
    Annual accounts 2012-15,2 k €
  15. 02/05/2011
    IncorporationPrivate limited company

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
International Medical Consulting CompanyCurrent
CBE, tracked since 27/09/2026
CBE
IMCC
accounts 2021 → 2025
Accounts 2025 · 2026-00434069
International Medical Consulting Company
accounts 2012 → 2020
Accounts 2020 · 2021-26700453

Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.